Loading...
Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia
BACKGROUND: The most advanced dengue vaccine candidate is a live-attenuated recombinant vaccine containing the four dengue viruses on the yellow fever vaccine backbone (CYD-TDV) developed by Sanofi Pasteur. Several analyses have been published on the safety and immunogenicity of the CYD-TDV vaccine...
Na minha lista:
| Udgivet i: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier Science
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504002/ https://ncbi.nlm.nih.gov/pubmed/26051515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.059 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|